Memorial Sloan-Kettering Cancer Center;Klinikum rechts der Isar der Technischen Universität München
发明人:
申请号：
EP18787923.4
公开号：
EP3612211A1
申请日:
2018.04.17
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed herein are methods for inhibiting irradiation- and chemo-induced impact on intestinal barrier function and graft versus host disease following allogeneic hematopoietic stem cell transplantation by targeting the RIG-I or STING signaling pathways.
